SCHEMBL31448463

SCHEMBL31448463

Nc1c(Br)cccc1-c1ccccc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 1/20 0.44
▸ HSD11B1 P28845 1/20 0.43
▸ PLA2G7 Q13093 1/20 0.43
▸ CYP2A6 P11509 1/20 0.41
▸ TSHR P16473 2/20 0.39
▸ ALDH1A1 P00352 4/20 0.39
▸ HPGD P15428 2/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ HKDC1 Q2TB90 1/20 0.39
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ LMNA P02545 2/20 0.38
▸ HSP90AA1 P07900 1/20 0.38
▸ HSP90AB1 P08238 1/20 0.38
▸ MAPK1 P28482 1/20 0.37
▸ TP53 P04637 1/20 0.36
▸ ELANE P08246 1/20 0.36
▸ PTPRC P08575 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29170812 0.83 HSD11B1 (0.43) DPP4HSD11B1PLA2G7CYP2A6TSHR
SCHEMBL15990084 0.81 CRHR1 (0.42) DPP4HSD11B1TSHRALDH1A1KDM4E
SCHEMBL9501878 0.80 — —
SCHEMBL2846646 0.80 HSD11B1 (0.55) DPP4HSD11B1PLA2G7CYP2A6TSHR
SCHEMBL30097499 0.80 HSD11B1 (0.55) DPP4HSD11B1PLA2G7CYP2A6TSHR
SCHEMBL10664062 0.80 HSD11B1 (0.55) DPP4HSD11B1PLA2G7CYP2A6TSHR
SCHEMBL30042309 0.80 — —
SCHEMBL28356286 0.78 HSD11B1 (0.46) DPP4HSD11B1PLA2G7CYP2A6TSHR
SCHEMBL19501161 0.78 HSD11B1 (0.53) DPP4HSD11B1PLA2G7CYP2A6TSHR
SCHEMBL18593183 0.75 HSD11B1 (0.43) DPP4HSD11B1PLA2G7CYP2A6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119343332-A 3, 4-Dihydro-quinolin-2 (1H) -one compounds 橘生药品工业株式会社 2025-01-21 — — CN disclosed
Send feedback